Two products. Two entirely different mechanisms.

Sculptra is poly-L-lactic acid — PLLA. When injected, PLLA particles trigger a controlled subclinical inflammatory response. Fibroblasts activate around the foreign material, begin depositing collagen, and the PLLA itself biodegrades over approximately 18 months — leaving behind your own tissue as the structural result. The collagen is yours. The PLLA is simply the instruction that built it. Results emerge gradually over two to three months and are documented to last over two years (Avelar et al., Journal of Cosmetic Dermatology, 2024; PMC11743305).

Radiesse is calcium hydroxylapatite — CaHA — microspheres suspended in a carboxymethylcellulose gel. The gel provides immediate structural lift from day one. The CaHA microspheres then stimulate neocollagenesis, neoelastinogenesis, and angiogenesis over the following months. When hyperdiluted, the gel volume is reduced and the product shifts from volumiser to pure biostimulator — a technique now supported by clinical and ultrasonographic evidence (Trindade de Almeida et al., Clinical, Cosmetic and Investigational Dermatology, 2023; PMID: 37255625).

They activate different biological pathways entirely

A 2024 gene expression study compared PLLA and CaHA directly in a randomised design with punch biopsy analysis at 90 days. The findings were unambiguous: PLLA stimulated more components of the extracellular matrix with less inflammatory response — a regenerative pathway. CaHA elicited a more inflammatory response — a pro-remodelling pathway. Different materials, different biology, different clinical profiles (McCarthy et al., Skin Research and Technology, 2024; PMC11163027).

This matters practically. It means the two products are not interchangeable. Choosing between them is not a preference — it is a clinical decision based on what the patient's anatomy, timeline, and treatment goals actually require.

What that means in practice

In my clinic, I reach for Sculptra when a patient wants gradual, long-arc restoration — where patience is available and the goal is rebuilding dermal architecture over time. Multiple sessions are required. Results are subtle in the early months and impressive at the 12–18 month mark.

I reach for Radiesse — or hyperdiluted Radiesse — when immediate structural correction is part of the goal alongside biostimulation, or when the patient's timeline does not accommodate Sculptra's slow build. One to two sessions. Visible from day one. Biostimulation continues underneath.

And I use both, in different sessions, for different regions of the same patient. They are not competitors. They are different tools with different jobs.

The house fire analogy from Still Alice applies here too. Before you choose, understand what you have. Then choose accordingly.

Thank you for reading. Sources: Avelar et al. (2024), Journal of Cosmetic Dermatology, PMC11743305 · Trindade de Almeida et al. (2023), CCID, PMID: 37255625 · McCarthy et al. (2024), Skin Research and Technology, PMC11163027.